Exact Sciences Corporation
EXASNASDAQHealthcare
$104.91
+$0.00(+0.00%)
Market Cap$20.0B
P/E Ratio—
52W High$104.98
52W Low$38.81
Exact Sciences Corporation (EXAS) · Balance Sheet
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · EXAS · as of 2026-06-10
Financial statements
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.96B | $1.04B | $0.78B | $0.63B | $1.03B |
| Net Receivables | $0.30B | $0.25B | $0.20B | $0.16B | $0.22B |
| Inventory | $0.17B | $0.16B | $0.13B | $0.12B | $0.10B |
| Total Current Assets | $1.56B | $1.57B | $1.19B | $0.98B | $1.43B |
| PP&E Net | $0.83B | $0.81B | $0.84B | $0.85B | $0.75B |
| Goodwill | $2.37B | $2.37B | $2.37B | $2.35B | $2.34B |
| Intangible Assets | $0.92B | $1.01B | $1.89B | $1.96B | $2.09B |
| Total Assets | $5.86B | $5.93B | $6.47B | $6.23B | $6.68B |
| Liabilities | |||||
| Short-Term Debt | $0.04B | $0.25B | $0.05B | $0.00B | $0.00B |
| Accounts Payable | $0.18B | $0.09B | $0.08B | $0.07B | $0.07B |
| Total Current Liabilities | $0.64B | $0.73B | $0.51B | $0.41B | $0.52B |
| Long-Term Debt | $2.33B | $2.32B | $2.31B | $2.24B | $2.18B |
| Total Liabilities | $3.46B | $3.53B | $3.33B | $3.18B | $3.30B |
| Stockholders Equity | |||||
| Retained Earnings | ($4.71B) | ($4.50B) | ($3.47B) | ($3.27B) | ($2.64B) |
| Total Stockholders Equity | $2.40B | $2.40B | $3.15B | $3.04B | $3.39B |
| Total Liab & Equity(computed) | $5.86B | $5.93B | $6.47B | $6.23B | $6.68B |
| Debt Summary | |||||
| Total Debt | $2.52B | $2.75B | $2.55B | $2.45B | $2.38B |
| Net Debt | $1.57B | $2.15B | $1.95B | $2.20B | $2.07B |
Data source: Financial Modeling Prep · Last updated: 2026-06-10 · USD · B
Explore more Exact Sciences Corporation data
About Exact Sciences Corporation (EXAS) Balance Sheet
Exact Sciences Corporation (EXAS) balance sheet shows total assets of $5.86B with cash of $0.96B. Total liabilities are $3.46B, total debt $2.52B, and stockholders equity $2.40B.
Frequently asked questions
EXAS · 4 questionsExact Sciences Corporation has total debt of $2.52B with net debt of $1.57B.
EXAS total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10